Halper Sadeh probes Sanara MedTech sale to MiMedx

The law firm is examining whether Sanara’s board secured the best available terms in a deal offering $33.00 in cash plus 0.4735 MiMedx shares for each Sanara share.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.